Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. [electronic resource]
Producer: 20040227Description: 947-54 p. digitalISSN:- 1538-3598
- Abciximab
- Aged
- Angioplasty, Balloon, Coronary
- Antibodies, Monoclonal -- therapeutic use
- Cardiac Catheterization
- Combined Modality Therapy
- Coronary Angiography
- Coronary Artery Bypass
- Drug Therapy, Combination
- Female
- Fibrinolytic Agents -- therapeutic use
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Male
- Middle Aged
- Myocardial Infarction -- diagnostic imaging
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Recombinant Proteins -- therapeutic use
- Stents
- Tissue Plasminogen Activator -- therapeutic use
- Tomography, Emission-Computed, Single-Photon
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.